1. Current and future approaches to ensure the viral safety of biopharmaceuticals;Brorson;Dev Biol Basel,2004
2. Roberts PL. Virus safety of cell-derived biological products; In: Davis J, Stacey G., editors. Medicines from animal cell culture. Chichester: John Wiley; 2007, in press.
3. International Conference on Harmonisation. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. Q5A (RI); 1999.
4. Committee for Proprietary Medicinal Products, European Medicines Evaluation Agency: Note for guidance on virus validation studies. The design, contribution and interpretation of studies validating the inactivation and removal of viruses. CPMP/BWP/268/95; 1996.